Inflammation as a new target in CV risk reduction

December 2022

Publication: Physicians Academy of Cardiovascular Education

Source / Author: PACE - CME

“Lowering LCL-c is the first, second and third thing we have to do to lower atherosclerotic event rates, but what can we do beyond LDL-c lowering?” asks Prof. Ridker. He talks about targeting inflammation in patients with residual CV risk.

View here

 

Read more

September 2023

Author: Caristo Sponsored Symposium

Caristo at SCCT 2023 – Raising the bar for coronary artery disease management

The Caristo team were delighted to meet with the CCTA community at the Society of Cardiovascular Computed Tomography (SCCT) Annual…

Read more

Cover photo for Caristo's Symposium at SCCT Symposium

February 2023

Author: Caristo Sponsored Symposium

The future of comprehensive cardiovascular risk prediction using CCTA | SCCT Edinburgh 2023

Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…